1Anini Y, Hansotia T, Brubaker PL. Muscarinic receptors control postprandial release of glucagon - like peptide - 1 : in vivo and in vitro studies in rats. Endocrinology, 2002,143 (6) :2420 - 2426
2Anini Y, Brubaker PL. Muscarinic receptors control glucagon - like peptide 1 secretion by human endocrine L cells. Endocrinology, 2003,144 (7) :3244 - 3250
3Gribble FM, Williams L, Simpson AK, et al. A novel glucose - sensing mechanism contributing to glucagon - like peptide - 1 secretion from the GLUTag cell line. Diabetes, 2003,52 ( 5 ) : 1147 - 1154
5Zander M, Madsbad S, Madsen JL, et al. Effect of 6 - week course of glucagon - like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel- group study. Lancet, 2002,359(9309) :824 - 830
6Egan JM, Meneilly GS, Elahi D. Effects of 1 - mo bolus subcutaneous administration of exendin - 4 in type 2 diabetes. Am J Physiol Endocrinol Metab, 2003,284(6) :E1072 - 1079
7MacDonald PE, El - Kholy W, Riedel MJ, et al. The multiple actions of GLP - 1 on the process of glucose - stimulated insulin secretion. Diabetes, 2002,51 Suppl 3 : S434 - 442
10Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004,27(5) : 1047-1053.
